Form 8-K - Current report:
SEC Accession No. 0001437749-25-024389
Filing Date
2025-08-01
Accepted
2025-08-01 16:31:22
Documents
13
Period of Report
2025-07-31
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20250731_8k.htm   iXBRL 8-K 32846
  Complete submission text file 0001437749-25-024389.txt   180249

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA govx-20250731.xsd EX-101.SCH 4061
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20250731_def.xml EX-101.DEF 13443
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20250731_lab.xml EX-101.LAB 17670
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20250731_pre.xml EX-101.PRE 13420
15 EXTRACTED XBRL INSTANCE DOCUMENT govx20250731_8k_htm.xml XML 4794
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 251176642
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)